Pesquisas alternativas:
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
die novel » dime novel (Expandir a Pesquisa), die novelle (Expandir a Pesquisa), dione novel (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
drug die » drug diet (Expandir a Pesquisa), drug did (Expandir a Pesquisa), drug dimer (Expandir a Pesquisa)
de level » de leval (Expandir a Pesquisa), de leve (Expandir a Pesquisa), de leves (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
die novel » dime novel (Expandir a Pesquisa), die novelle (Expandir a Pesquisa), dione novel (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
drug die » drug diet (Expandir a Pesquisa), drug did (Expandir a Pesquisa), drug dimer (Expandir a Pesquisa)
de level » de leval (Expandir a Pesquisa), de leve (Expandir a Pesquisa), de leves (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
1
Por van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Publicado no Rheumatol Ther (2018)
“... antirheumatic drugs (csDMARDs) or corticosteroids altered the response or safety outcomes to baricitinib...”Publicado no Rheumatol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Andrés-Guerrero, Vanessa, Perucho-González, Lucía, García-Feijoo, Julián, Morales-Fernández, Laura, Saenz-Francés, Federico, Herrero-Vanrell, Rocío, Júlvez, Luis Pablo, Llorens, Vicente Polo, Martínez-de-la-Casa, José María, Konstas, Anastasios-Georgios P.
Publicado no Adv Ther (2016)
“... levels. In this article we review current perspectives on the use of anti-VEGF drugs as adjuvant therapy...”Publicado no Adv Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... by the pineal gland and enterochromaffin cells which control sleep and gastrointestinal motility. Low levels...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Wang, Wei-Peng, Ho, Pui Yan, Chen, Qiu-Xia, Addepalli, Balasubrahmanyam, Limbach, Patrick A., Li, Mei-Mei, Wu, Wen-Juan, Jilek, Joseph L., Qiu, Jing-Xin, Zhang, Hong-Jian, Li, Tianhong, Wun, Theodore, White, Ralph DeVere, Lam, Kit S., Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2015)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Zimmermann, Maike, Wang, Si-Si, Zhang, Hongyong, Lin, Tzu-yin, Malfatti, Michael, Haack, Kurt, Ognibene, Ted, Yang, Hongyuan, Airhart, Susan, Turteltaub, Kenneth W., Cimino, George D., Tepper, Clifford G., Drakaki, Alexandra, Chamie, Karim, de Vere White, Ralph, Pan, Chong-xian, Henderson, Paul T.
Publicado no Mol Cancer Ther (2016)
“... to test the possibility that another drug in the regimen could cause a response. The mice were dosed...”Publicado no Mol Cancer Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por May FEB
Publicado em 2014-05-01
“..., and palliative control of advanced breast cancer. Next, the potential of novel drugs that target DNA repair...”Publicado em 2014-05-01
Obter o texto integral
Artigo
7
“... and was related to serum and cerebrospinal fluid drug levels. Repeated 2-week treatment with risperidone...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Simsek, Melek, Meijer, Berrie, Mulder, Chris J. J., van Bodegraven, Adriaan A., de Boer, Nanne K. H.
Publicado no Ther Drug Monit (2017)
“.... In the current therapeutic drug monitoring, metabolite levels are assessed in erythrocytes, whereas leukocytes...”Publicado no Ther Drug Monit (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... levels, and σ-1 receptor binding and modulation). These additional functions of pridopidine suggest...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Rezende, Vinicius Marcondes, Rivellis, Ariane, Novaes, Mafalda Megumi Yoshinaga, de Alencar Fisher Chamone, Dalton, Bendit, Israel
Publicado em 2013
“... standard for monitoring patients, and imatinib blood levels have also become an important tool...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Tyler, Paul M., Servos, Mariah M., de Vries, Romy C., Klebanov, Boris, Kashyap, Trinayan, Sacham, Sharon, Landesman, Yosef, Dougan, Michael, Dougan, Stephanie K.
Publicado no Mol Cancer Ther (2017)
“... activation but clinically relevant once and twice weekly dosing schedules that incorporate sufficient drug...”Publicado no Mol Cancer Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Salviato Balbão, Marina, Cecílio Hallak, Jaime Eduardo, Arcoverde Nunes, Emerson, Homem de Mello, Mauricio, Triffoni-Melo, Andresa de Toledo, Ferreira, Flavia Isaura de Santi, Chaves, Cristiano, Durão, Ana Maria Sertori, Ramos, Adriana Pelegrino Pinho, de Souza Crippa, José Alexandre, Queiroz, Regina Helena Costa
Publicado em 2014
“...OBJECTIVE: Olanzapine is an atypical antipsychotic drug used to treat schizophrenia. Some...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Schlesinger, Naomi, De Meulemeester, Marc, Pikhlak, Andrey, Yücel, A Eftal, Richard, Dominik, Murphy, Valda, Arulmani, Udayasankar, Sallstig, Peter, So, Alexander
Publicado em 2011
“...-steroidal anti-inflammatory drugs and/or colchicine were randomized to receive a single subcutaneous dose...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Vo, Pamela, Paris, Nicolas, Bilitou, Aikaterini, Valena, Tomas, Fang, Juanzhi, Naujoks, Christel, Cameron, Ann, de Reydet de Vulpillieres, Frederic, Cadiou, Francois
Publicado no Neurol Ther (2018)
“... commonly reported to have at least moderate to severe levels of pain, corresponding to the inability...”Publicado no Neurol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Castle, Jessica R., DeVries, J. Hans, Kovatchev, Boris
Publicado no Diabetes Technol Ther (2017)
“... Food and Drug Administration approval, and more systems are likely to follow. As the field of AID...”Publicado no Diabetes Technol Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“... clozapine dose or level, or only as remedial treatment. In this review, we examine the relevant literature...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Kim, Tiffany, Jancel, Timothy, Kumar, Parag, Freeman, Alexandra F.
Publicado no J Clin Pharm Ther (2015)
“... isavuconazole and tacrolimus there are no recommendations on dose-adjustment when these drugs are given...”Publicado no J Clin Pharm Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“... of primary cancer, tumor stage, treatment selection, serum levels of glutamic-pyruvic transaminase, albumin...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Ho, Pui Yan, Duan, Zhijian, Batra, Neelu, Jilek, Joseph L., Tu, Mei-Juan, Qiu, Jing-Xin, Hu, Zihua, Wun, Theodore, Lara, Primo N., DeVere White, Ralph W., Chen, Hong-Wu, Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2018)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Kamola, Piotr J., Maratou, Klio, Wilson, Paul A., Rush, Kay, Mullaney, Tanya, McKevitt, Tom, Evans, Paula, Ridings, Jim, Chowdhury, Probash, Roulois, Aude, Fairchild, Ann, McCawley, Sean, Cartwright, Karen, Gooderham, Nigel J., Gant, Timothy W., Moores, Kitty, Hughes, Stephen A., Edbrooke, Mark R., Clark, Kenneth, Parry, Joel D.
Publicado no Mol Ther Nucleic Acids (2017)
“... single-dose (3-day) screen with streamlined endpoints (i.e., plasma transaminase levels and liver weights...”Publicado no Mol Ther Nucleic Acids (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo